

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mononuclear cell migration (GO:0071675) | 5.84858384 |
| 2 | surfactant homeostasis (GO:0043129) | 5.59391650 |
| 3 | immunoglobulin mediated immune response (GO:0016064) | 5.52247341 |
| 4 | regulation of macrophage chemotaxis (GO:0010758) | 5.35662626 |
| 5 | complement activation, classical pathway (GO:0006958) | 5.23538067 |
| 6 | eosinophil chemotaxis (GO:0048245) | 4.68685494 |
| 7 | glycosphingolipid catabolic process (GO:0046479) | 4.68650086 |
| 8 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.64440143 |
| 9 | complement activation (GO:0006956) | 4.63442427 |
| 10 | regulation of cholesterol storage (GO:0010885) | 4.34465761 |
| 11 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.27860941 |
| 12 | glycolipid catabolic process (GO:0019377) | 4.24932790 |
| 13 | eosinophil migration (GO:0072677) | 4.21452084 |
| 14 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.14504123 |
| 15 | chemical homeostasis within a tissue (GO:0048875) | 4.13052225 |
| 16 | regulation of hypersensitivity (GO:0002883) | 4.06797765 |
| 17 | B cell mediated immunity (GO:0019724) | 4.04366842 |
| 18 | regulation of antigen processing and presentation (GO:0002577) | 3.97551071 |
| 19 | peptide catabolic process (GO:0043171) | 3.91467341 |
| 20 | oligosaccharide catabolic process (GO:0009313) | 3.89434419 |
| 21 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86473393 |
| 22 | ceramide catabolic process (GO:0046514) | 3.75136481 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.70760223 |
| 24 | negative regulation of complement activation (GO:0045916) | 3.69005982 |
| 25 | apoptotic cell clearance (GO:0043277) | 3.64418585 |
| 26 | cellular response to interferon-gamma (GO:0071346) | 3.59992542 |
| 27 | T-helper 1 type immune response (GO:0042088) | 3.57417491 |
| 28 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.52146014 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.50139225 |
| 30 | response to interferon-gamma (GO:0034341) | 3.42800841 |
| 31 | phagocytosis, recognition (GO:0006910) | 3.42566715 |
| 32 | protein activation cascade (GO:0072376) | 3.41448916 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 3.40515945 |
| 34 | detection of other organism (GO:0098543) | 3.39666132 |
| 35 | detection of bacterium (GO:0016045) | 3.38106406 |
| 36 | cellular extravasation (GO:0045123) | 3.37851278 |
| 37 | negative regulation of humoral immune response (GO:0002921) | 3.34704582 |
| 38 | positive regulation of type 2 immune response (GO:0002830) | 3.32303665 |
| 39 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.31075562 |
| 40 | keratan sulfate catabolic process (GO:0042340) | 3.30599474 |
| 41 | amino sugar catabolic process (GO:0046348) | 3.26972964 |
| 42 | phagocytosis, engulfment (GO:0006911) | 3.24705608 |
| 43 | negative regulation of protein activation cascade (GO:2000258) | 3.23315243 |
| 44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23176174 |
| 45 | response to thyroid hormone (GO:0097066) | 3.22607059 |
| 46 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.19016150 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.17645080 |
| 48 | barbed-end actin filament capping (GO:0051016) | 3.09198864 |
| 49 | negative regulation of interleukin-2 production (GO:0032703) | 3.07318614 |
| 50 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.04458150 |
| 51 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.99622797 |
| 52 | sphingolipid catabolic process (GO:0030149) | 2.97671734 |
| 53 | humoral immune response (GO:0006959) | 2.95559614 |
| 54 | myeloid dendritic cell differentiation (GO:0043011) | 2.94675373 |
| 55 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.93508803 |
| 56 | positive thymic T cell selection (GO:0045059) | 2.92432593 |
| 57 | positive regulation of neutrophil migration (GO:1902624) | 2.92173496 |
| 58 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.92173496 |
| 59 | cellular response to type I interferon (GO:0071357) | 2.91309343 |
| 60 | type I interferon signaling pathway (GO:0060337) | 2.91309343 |
| 61 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90821716 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90232056 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 2.89301715 |
| 64 | virion attachment to host cell (GO:0019062) | 2.89301715 |
| 65 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.86756838 |
| 66 | response to type I interferon (GO:0034340) | 2.86505912 |
| 67 | positive regulation of cholesterol efflux (GO:0010875) | 2.85702946 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.85634768 |
| 69 | membrane lipid catabolic process (GO:0046466) | 2.84652355 |
| 70 | regulation of granulocyte chemotaxis (GO:0071622) | 2.84477887 |
| 71 | negative regulation of innate immune response (GO:0045824) | 2.83727748 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.81499300 |
| 73 | angiogenesis involved in wound healing (GO:0060055) | 2.81321711 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77398997 |
| 75 | lipoxygenase pathway (GO:0019372) | 2.76923896 |
| 76 | lymphocyte chemotaxis (GO:0048247) | 2.75662971 |
| 77 | regulation of monocyte chemotaxis (GO:0090025) | 2.75568184 |
| 78 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.75428490 |
| 79 | macrophage chemotaxis (GO:0048246) | 2.74639779 |
| 80 | T cell costimulation (GO:0031295) | 2.73002560 |
| 81 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.72444784 |
| 82 | regulation of cholesterol esterification (GO:0010872) | 2.71771099 |
| 83 | monocyte chemotaxis (GO:0002548) | 2.71053642 |
| 84 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.71029374 |
| 85 | detection of biotic stimulus (GO:0009595) | 2.69946213 |
| 86 | phospholipid efflux (GO:0033700) | 2.69911593 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 2.68759457 |
| 88 | lymphocyte costimulation (GO:0031294) | 2.68640349 |
| 89 | membrane invagination (GO:0010324) | 2.68519819 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.66933778 |
| 91 | response to peptidoglycan (GO:0032494) | 2.65408190 |
| 92 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.64952620 |
| 93 | regulation of type 2 immune response (GO:0002828) | 2.64308394 |
| 94 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.62926523 |
| 95 | granulocyte activation (GO:0036230) | 2.62764246 |
| 96 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.62365393 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62154265 |
| 98 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.61742863 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.61330101 |
| 100 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.59533757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.64206524 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.21071997 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55753798 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70786950 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.56586995 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.54100992 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.90097889 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86660740 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70640005 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.64922170 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60448248 |
| 12 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.49883784 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29030853 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24221588 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14089060 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03585302 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02777487 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99511836 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90113143 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82170363 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79954662 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69445401 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66046569 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59863502 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59689471 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55965484 |
| 27 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.53348819 |
| 28 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51915768 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51603766 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48164694 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46812537 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42853355 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41954847 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39748706 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39268496 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38479838 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35293246 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33158749 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32952785 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32811954 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30513199 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30045861 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30013511 |
| 44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27420340 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24808460 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23660868 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23084007 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22322455 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22157192 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22018079 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21488063 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20028026 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19773654 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19483178 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15502774 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13626550 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12726864 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09492231 |
| 59 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09340272 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08324725 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08197785 |
| 62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06837296 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06027042 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05522218 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05511980 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04839613 |
| 67 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04420638 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04351410 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03170177 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02382164 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02151954 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98698595 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95238476 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94859918 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94731281 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94536606 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94066070 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92835460 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92480803 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92407756 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91837504 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90615924 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89193967 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88907336 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87625219 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85340128 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84392622 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 0.83898917 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 0.81462370 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80376476 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80206415 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79792976 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76409599 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75903270 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75833506 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.75528798 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74772442 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.74103140 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73587551 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73147870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 5.62541044 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.44561397 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.42562622 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.30329869 |
| 5 | MP0003724_increased_susceptibility_to | 3.13877190 |
| 6 | MP0000604_amyloidosis | 2.96872251 |
| 7 | MP0004782_abnormal_surfactant_physiolog | 2.92576481 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.90344051 |
| 9 | MP0003303_peritoneal_inflammation | 2.90169817 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.73093810 |
| 11 | MP0005387_immune_system_phenotype | 2.69740238 |
| 12 | MP0001790_abnormal_immune_system | 2.69740238 |
| 13 | MP0005671_abnormal_response_to | 2.69660918 |
| 14 | MP0006082_CNS_inflammation | 2.52274896 |
| 15 | MP0002419_abnormal_innate_immunity | 2.41116887 |
| 16 | MP0003436_decreased_susceptibility_to | 2.40960790 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.37860400 |
| 18 | MP0005025_abnormal_response_to | 2.35994007 |
| 19 | MP0009785_altered_susceptibility_to | 2.28970842 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.14086092 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.13508267 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.12395463 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.98090235 |
| 24 | MP0000343_altered_response_to | 1.90954408 |
| 25 | MP0001800_abnormal_humoral_immune | 1.83243699 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.81384587 |
| 27 | MP0005360_urolithiasis | 1.78358573 |
| 28 | MP0000685_abnormal_immune_system | 1.77376740 |
| 29 | MP0002723_abnormal_immune_serum | 1.76573305 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.70936681 |
| 31 | MP0003329_amyloid_beta_deposits | 1.66544314 |
| 32 | MP0005257_abnormal_intraocular_pressure | 1.65514466 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.65161709 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.64512179 |
| 35 | MP0009764_decreased_sensitivity_to | 1.63780496 |
| 36 | MP0005365_abnormal_bile_salt | 1.63648222 |
| 37 | MP0003075_altered_response_to | 1.58137792 |
| 38 | MP0003448_altered_tumor_morphology | 1.57282583 |
| 39 | MP0001958_emphysema | 1.55308932 |
| 40 | MP0002405_respiratory_system_inflammati | 1.54595971 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.52944790 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.52914811 |
| 43 | MP0001819_abnormal_immune_cell | 1.52158649 |
| 44 | MP0008004_abnormal_stomach_pH | 1.44987074 |
| 45 | MP0004947_skin_inflammation | 1.39046691 |
| 46 | MP0008469_abnormal_protein_level | 1.32898564 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.30277879 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.28961889 |
| 49 | MP0001853_heart_inflammation | 1.28395818 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.26910321 |
| 51 | MP0005166_decreased_susceptibility_to | 1.26894783 |
| 52 | MP0005310_abnormal_salivary_gland | 1.26841156 |
| 53 | MP0000249_abnormal_blood_vessel | 1.23098087 |
| 54 | MP0002933_joint_inflammation | 1.22377703 |
| 55 | MP0003690_abnormal_glial_cell | 1.21463977 |
| 56 | MP0005275_abnormal_skin_tensile | 1.19348320 |
| 57 | MP0000920_abnormal_myelination | 1.18363419 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.15345452 |
| 59 | MP0003828_pulmonary_edema | 1.10604606 |
| 60 | MP0005164_abnormal_response_to | 1.05640085 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.04608991 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.03584039 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.02922948 |
| 64 | MP0001542_abnormal_bone_strength | 1.01274159 |
| 65 | MP0000858_altered_metastatic_potential | 1.00563111 |
| 66 | MP0000716_abnormal_immune_system | 1.00289521 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 0.99807787 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.97600920 |
| 69 | MP0002009_preneoplasia | 0.93248193 |
| 70 | MP0002133_abnormal_respiratory_system | 0.92762011 |
| 71 | MP0005388_respiratory_system_phenotype | 0.92762011 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 0.92661566 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.92201318 |
| 74 | MP0000371_diluted_coat_color | 0.91245304 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.87975173 |
| 76 | MP0002006_tumorigenesis | 0.87863356 |
| 77 | MP0004510_myositis | 0.87469121 |
| 78 | MP0002254_reproductive_system_inflammat | 0.87140095 |
| 79 | MP0005165_increased_susceptibility_to | 0.83573045 |
| 80 | MP0005023_abnormal_wound_healing | 0.81444628 |
| 81 | MP0001851_eye_inflammation | 0.80863456 |
| 82 | MP0002090_abnormal_vision | 0.80537034 |
| 83 | MP0001756_abnormal_urination | 0.80004487 |
| 84 | MP0009763_increased_sensitivity_to | 0.78233046 |
| 85 | MP0004883_abnormal_blood_vessel | 0.76494078 |
| 86 | MP0005390_skeleton_phenotype | 0.74992583 |
| 87 | MP0002429_abnormal_blood_cell | 0.74297063 |
| 88 | MP0003091_abnormal_cell_migration | 0.74246252 |
| 89 | MP0003279_aneurysm | 0.74124489 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 0.74074973 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.73261975 |
| 92 | MP0003795_abnormal_bone_structure | 0.71814166 |
| 93 | MP0005408_hypopigmentation | 0.71216706 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.69188880 |
| 95 | MP0002796_impaired_skin_barrier | 0.67570729 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 0.65884465 |
| 97 | MP0009278_abnormal_bone_marrow | 0.63840337 |
| 98 | MP0008260_abnormal_autophagy | 0.63604947 |
| 99 | MP0002398_abnormal_bone_marrow | 0.63437015 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.61961568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.45396966 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.45396966 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.45396966 |
| 4 | Glomerulonephritis (HP:0000099) | 5.79838580 |
| 5 | Complement deficiency (HP:0004431) | 5.21310963 |
| 6 | Interstitial pulmonary disease (HP:0006530) | 4.58777828 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.41599170 |
| 8 | Abnormality of complement system (HP:0005339) | 4.37133600 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.03912794 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.91446720 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.82565188 |
| 12 | Prostate neoplasm (HP:0100787) | 3.73667051 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.58404094 |
| 14 | Disinhibition (HP:0000734) | 3.55948823 |
| 15 | Premature loss of primary teeth (HP:0006323) | 3.47127103 |
| 16 | Nephritis (HP:0000123) | 3.40617988 |
| 17 | Axonal loss (HP:0003447) | 3.35301679 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.32936226 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.21126869 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.18888747 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.17759101 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 3.17759101 |
| 23 | Loss of speech (HP:0002371) | 3.16778547 |
| 24 | Thick nail (HP:0001805) | 3.12795019 |
| 25 | Malnutrition (HP:0004395) | 2.93746644 |
| 26 | Abnormality of the prostate (HP:0008775) | 2.89217712 |
| 27 | Neurofibrillary tangles (HP:0002185) | 2.78824787 |
| 28 | Pustule (HP:0200039) | 2.67885538 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66916829 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.66619202 |
| 31 | Nuclear cataract (HP:0100018) | 2.65848928 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64648694 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64648694 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64648694 |
| 35 | Gingivitis (HP:0000230) | 2.62295900 |
| 36 | Mutism (HP:0002300) | 2.61406879 |
| 37 | Purpura (HP:0000979) | 2.58548138 |
| 38 | Esophageal neoplasm (HP:0100751) | 2.53855851 |
| 39 | Neoplasm of head and neck (HP:0012288) | 2.53855851 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.53694156 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.48183073 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48183073 |
| 43 | Albinism (HP:0001022) | 2.43324931 |
| 44 | Myocardial infarction (HP:0001658) | 2.43301366 |
| 45 | Apathy (HP:0000741) | 2.41917945 |
| 46 | Abnormality of the nasal mucosa (HP:0000433) | 2.39074988 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.38866064 |
| 48 | Hypergammaglobulinemia (HP:0010702) | 2.38719318 |
| 49 | Recurrent skin infections (HP:0001581) | 2.38244512 |
| 50 | Diminished motivation (HP:0000745) | 2.35287811 |
| 51 | Hemoptysis (HP:0002105) | 2.34806423 |
| 52 | Periodontitis (HP:0000704) | 2.17513428 |
| 53 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.16156913 |
| 54 | Increased serum ferritin (HP:0003281) | 2.11297684 |
| 55 | Pulmonary fibrosis (HP:0002206) | 2.09627564 |
| 56 | Obstructive lung disease (HP:0006536) | 2.08831626 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08831626 |
| 58 | Metaphyseal irregularity (HP:0003025) | 2.06810104 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.05063640 |
| 60 | Increased IgE level (HP:0003212) | 2.04414326 |
| 61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04409788 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 2.01523910 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 10.0465184 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 1.98020180 |
| 65 | Retinal atrophy (HP:0001105) | 1.97530656 |
| 66 | Restrictive lung disease (HP:0002091) | 1.94859774 |
| 67 | Mucosal telangiectasiae (HP:0100579) | 1.94329249 |
| 68 | Bone cyst (HP:0012062) | 1.90967516 |
| 69 | Pulmonary hypertension (HP:0002092) | 1.90754912 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 1.90512475 |
| 71 | Erythema (HP:0010783) | 1.89786769 |
| 72 | Urticaria (HP:0001025) | 1.85962874 |
| 73 | Increased CSF protein (HP:0002922) | 1.85687043 |
| 74 | Inappropriate behavior (HP:0000719) | 1.85186091 |
| 75 | Palmoplantar hyperkeratosis (HP:0000972) | 1.84930613 |
| 76 | Hematochezia (HP:0002573) | 1.83201192 |
| 77 | Peripheral demyelination (HP:0011096) | 1.83110552 |
| 78 | Dementia (HP:0000726) | 1.79100873 |
| 79 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76072934 |
| 80 | J-shaped sella turcica (HP:0002680) | 1.75988546 |
| 81 | Vasculitis (HP:0002633) | 1.75784014 |
| 82 | Abnormality of the periventricular white matter (HP:0002518) | 1.75699959 |
| 83 | Bone pain (HP:0002653) | 1.74480262 |
| 84 | Amyloidosis (HP:0011034) | 1.73068751 |
| 85 | Conjunctival telangiectasia (HP:0000524) | 1.72882936 |
| 86 | Gangrene (HP:0100758) | 1.72446629 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 1.70851151 |
| 88 | Nasal polyposis (HP:0100582) | 1.70843585 |
| 89 | Meningitis (HP:0001287) | 1.69463843 |
| 90 | Basal ganglia calcification (HP:0002135) | 1.68902946 |
| 91 | Palmar hyperkeratosis (HP:0010765) | 1.67552474 |
| 92 | Hepatosplenomegaly (HP:0001433) | 1.66173620 |
| 93 | Diaphragmatic weakness (HP:0009113) | 1.64751125 |
| 94 | Progressive neurologic deterioration (HP:0002344) | 1.64425575 |
| 95 | Osteomyelitis (HP:0002754) | 1.61383339 |
| 96 | Ocular albinism (HP:0001107) | 1.61349065 |
| 97 | Recurrent fungal infections (HP:0002841) | 1.61276534 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 1.61170563 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60636847 |
| 100 | Upper motor neuron abnormality (HP:0002127) | 1.60520225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.93371295 |
| 2 | PDK2 | 3.11904678 |
| 3 | ERN1 | 3.07769242 |
| 4 | TYK2 | 3.07143121 |
| 5 | DMPK | 2.51283826 |
| 6 | MAP3K14 | 2.39764256 |
| 7 | IRAK3 | 2.33309459 |
| 8 | MAP4K1 | 2.31820079 |
| 9 | TGFBR2 | 2.30868721 |
| 10 | ZAP70 | 2.21430462 |
| 11 | TXK | 2.11272934 |
| 12 | TBK1 | 2.05335380 |
| 13 | BMPR2 | 1.85330317 |
| 14 | RIPK4 | 1.81163273 |
| 15 | CDC42BPA | 1.79035258 |
| 16 | JAK3 | 1.72184014 |
| 17 | DDR2 | 1.69244875 |
| 18 | GRK7 | 1.65805260 |
| 19 | RIPK1 | 1.59023395 |
| 20 | MAP3K3 | 1.57520198 |
| 21 | IKBKE | 1.57229735 |
| 22 | CSK | 1.55557297 |
| 23 | FGFR4 | 1.54676479 |
| 24 | MATK | 1.51362656 |
| 25 | KIT | 1.46057708 |
| 26 | EPHA3 | 1.45814377 |
| 27 | JAK1 | 1.42237038 |
| 28 | IKBKB | 1.37272742 |
| 29 | TRIM28 | 1.36262595 |
| 30 | FGR | 1.32015717 |
| 31 | PRPF4B | 1.29766835 |
| 32 | ACVR1B | 1.29504648 |
| 33 | LATS2 | 1.27937325 |
| 34 | CSF1R | 1.26678803 |
| 35 | MAP3K13 | 1.24167296 |
| 36 | CDK6 | 1.22865515 |
| 37 | RPS6KA2 | 1.22235529 |
| 38 | MAPK15 | 1.15532721 |
| 39 | LYN | 1.14616856 |
| 40 | MAP3K11 | 1.13400716 |
| 41 | SYK | 1.13163277 |
| 42 | ABL2 | 1.12977846 |
| 43 | JAK2 | 1.08153571 |
| 44 | EPHB1 | 1.06570728 |
| 45 | MAP3K12 | 1.04945957 |
| 46 | MAP3K6 | 1.01438776 |
| 47 | NME2 | 1.00578215 |
| 48 | MAP3K1 | 0.98853800 |
| 49 | FGFR3 | 0.97224865 |
| 50 | IRAK4 | 0.95838870 |
| 51 | FES | 0.95837219 |
| 52 | MYLK | 0.94826043 |
| 53 | RPS6KL1 | 0.92520673 |
| 54 | RPS6KC1 | 0.92520673 |
| 55 | TAOK2 | 0.87657447 |
| 56 | PDPK1 | 0.87444160 |
| 57 | MAPK7 | 0.85190375 |
| 58 | HCK | 0.82037296 |
| 59 | ADRBK2 | 0.80461619 |
| 60 | MST1R | 0.78869441 |
| 61 | MAPKAPK3 | 0.77180664 |
| 62 | LRRK2 | 0.76957935 |
| 63 | RPS6KA6 | 0.76743447 |
| 64 | PAK4 | 0.74949740 |
| 65 | ABL1 | 0.74526846 |
| 66 | MAP2K3 | 0.74151032 |
| 67 | TIE1 | 0.71992293 |
| 68 | LCK | 0.67855711 |
| 69 | IRAK1 | 0.66721300 |
| 70 | MAPK12 | 0.65335776 |
| 71 | CDK9 | 0.64336011 |
| 72 | MAPKAPK2 | 0.61296072 |
| 73 | FYN | 0.60639252 |
| 74 | HIPK2 | 0.58816598 |
| 75 | TGFBR1 | 0.58109574 |
| 76 | TAOK1 | 0.56100110 |
| 77 | FER | 0.52017905 |
| 78 | MOS | 0.51479012 |
| 79 | MAP2K6 | 0.51147590 |
| 80 | EPHB2 | 0.50442035 |
| 81 | IGF1R | 0.49771695 |
| 82 | EGFR | 0.49535636 |
| 83 | PRKD1 | 0.49217271 |
| 84 | PRKG2 | 0.49125282 |
| 85 | PDK1 | 0.48781134 |
| 86 | PDGFRB | 0.48152264 |
| 87 | MAP3K5 | 0.47221191 |
| 88 | PDGFRA | 0.46359945 |
| 89 | CHUK | 0.44794167 |
| 90 | TESK1 | 0.43851402 |
| 91 | MARK3 | 0.42550912 |
| 92 | NTRK2 | 0.41671845 |
| 93 | MAP2K2 | 0.40584799 |
| 94 | MARK2 | 0.39142611 |
| 95 | NEK9 | 0.38668560 |
| 96 | RPS6KA5 | 0.37574924 |
| 97 | CAMKK2 | 0.35999784 |
| 98 | NEK6 | 0.35907145 |
| 99 | PRKACG | 0.35491791 |
| 100 | INSR | 0.34084888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.00471514 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.07803246 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.77696781 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.44548386 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.44451374 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.11381858 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.95876381 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.88617725 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75144360 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.73288877 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.57605538 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.36123521 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.35880993 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.26744013 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17009350 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 2.10821670 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.93451837 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82806581 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79201884 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78540379 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.75093704 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49541070 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41302833 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35338541 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.29199549 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.19846748 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.14082463 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08728506 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08483958 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06219018 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02697097 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.02551670 |
| 33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00550378 |
| 34 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90942401 |
| 35 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88280597 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 0.85638489 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83601701 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83462773 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82585568 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82087953 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81873991 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80713668 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78453321 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76183007 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.75839296 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74626391 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70502049 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69265042 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68010458 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63051018 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62315455 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61585427 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59745635 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59340400 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56003763 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54722690 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.49353704 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48755291 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48211653 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48128792 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.47998444 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47590278 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46997654 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43815905 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43477293 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43050498 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42738303 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.40768373 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39927937 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37863695 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.37752132 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35624962 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33877868 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.30996168 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28283039 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.26382423 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26169449 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24073857 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.22568636 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22006091 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.21909547 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.21426491 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21041073 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.19549346 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17302423 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17144583 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15880347 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.15366093 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14591759 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.13951570 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13048004 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.13008750 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12571246 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11687138 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11320130 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.11089968 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07870311 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.07329311 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07050536 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06940558 |

